Model
Edge
CNS Pharmaceuticals Inc.
CNSP
Filing type
8-K
Filing date
Nov 20, 2025
Updated
Nov 21, 2025 ยท 3:19 PM
Copy reference
Filing
8-K
Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Shareholder votes
Exhibits
EX-3.1
CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION
EX-10.1
2020 EQUITY PLAN (AS AMENDED AND RESTATED)
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic